Some pyridazinone and phthalazinone derivatives and their vasodilator activities

Archives of Pharmacal Research

Volumn 27, Issue 1, 2004, Pages 13-18

  Demirayak, Seref ^a   Karaburun, Ahmet Cagri ^a   Kayagil, Ismail ^a   Erol, Kevser ^b   Sirmagul, Basar ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Phthalazinone; Pyridazinone; Vasodilator activity

Indexed keywords

CLONIDINE; IMIDAZOLE DERIVATIVE; PHTHALAZINE DERIVATIVE; POTASSIUM CHLORIDE; PYRIDAZINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; INSTRUMENTATION; MALE; METHODOLOGY; PHYSIOLOGY; RAT; SHEEP; SYNTHESIS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CAROTID ARTERIES; CLONIDINE; DRUG EVALUATION, PRECLINICAL; FEMALE; IMIDAZOLES; MALE; MUSCLE, SMOOTH, VASCULAR; PHTHALAZINES; POTASSIUM CHLORIDE; PYRIDAZINES; RATS; SHEEP; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 6944221799     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980038     Document Type: Article

References (26)

1. Betti, L., Floridi, M., Giannaccini, G., Manetti, F., Strappaghetti, G., Tafi, A., and Botta, M., α1-Adrenoceptor antagonists. 5. Pyridazinone-arylpiperazines. Probing the influence on affinity and selectivity of both ortho-Alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus. Bioorg. Med. Chem. Lett., 13, 171-173 (2003).
2. Cignarella, G., Barlocco, D., Pinna, G. A., Loriga, M., Curzu, M., Tofanetti, O., Germini, M., Cazzulani, P., and Cavalletti, E., Synthesis and biological evaluations of substituted benzo[h]-cinnolinones and 3-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5 H-indeno[1,2-c]pyridazinones. J. Med. Chem., 32, 2277-2282 (1989).
3. Combs, D. W., Rampulla, M. S., Bell, S. C., Klaubert, D. H., Tobia, A. J., Falotico, R., Haertlein, B., Lakas-Weiss, C., and Moore, J. B., 6-Benzoxazinylpyridazin-3-ones, Potent, longacting positive inotrope and peripheral vasodilator agents. J. Med. Chem., 33, 380-386 (1990).
4. Corsano, S., Vezza, R., Scapicchi, R., Foresi, S., Strappaghetti, G., Nenci, G. G., and Gresele, P., New pyridazinone derivatives as inhibitors of platelet aggregation. Eur. J. Med. Chem., 30, 627-631 (1995).
5. Curran, W. V. and Ross, A., 6-Phenyl-4,5-dihydro-3-(2H)-pyridazinones, A series of hypotensive agents, J. Med. Chem., 17, 273-281 (1974).
6. Demirayak, S., Benkli, K., Karaburun, A. C., Erol, K., and Boydag, S., Some 1-substituted 3-aryl-1,4-dihydro-1,2,4-triazino[4,3-a]benzimidazoles and their vasodilatory activities. Farmaco, 52, 741-744 (1997).
7. Foye, W. O., Lemke, T. L., and Williams, D. A., Principles of Medicinal Chemistry, 4th Ed., Williams and Wilkins. London, 345-387, 499-534 (1995).
8. Haikala, H. O., Honkanen, E. J., Lonnberg, K. K., Nore, P. T., Pystynen, J. J., Luiro, A. M., and Pippuri, A. K., Preparation of arylazinones for treatment of congestive heart failure, Brit. UK Pat. Appl., EP 597,540. C.A. 121, 114, 228967 (1997).
9. Heinisch, G. and Kopelent-Frank, H., Pharmacologically active pyridazine derivatives, Part II. Prog. Med. Chem., 29, 141-183 (1992).
10. Laguna, R., Rodriguez-Linarez, B., Cano, E., Estevez, I., Ravina, E., and Sotelo, E., Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors. Chem. Pharm. Bull., 45, 1151-1155 (1997).
11. McEvoy, F. J. and Allen, Jr. G. R., 6-(Substituted phenyl)-5-substituted- 4,5-dihydro-3(2H)-pyridazinones. J. Med. Chem., 17, 281-286 (1974).
12. Montero-Lastres, A., Fraiz, N., Laguna, R., Cano, E., Esteves, I., and Ravina, E. Pyridazines XVIII. 6-aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets. Biol. Pharm. Bull., 22, 1376-1379 (1999).
13. Seki, T., Nakao, T., Masuda, T., Hasumi, K., Gotanda, K., Ishimori, T., Honma, S., Minami, N., Shibata, K., and Yasuda, K., Studies on agents with vasodilator and β-blocking activities. IV, Chem. Pharm. Bull., 44, 2061-2069 (1996).
14. Sircar, I., Weishaar, R. E., Kobylarz, D., Moos, W. H., and Bristol, J. A., Cardiotonic agents, 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1 H)-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds, Structureactivity relationships and correlation with in vivo positive inotropic activity. J. Med. Chem., 30, 1955-1962 (1987).
15. Sotelo, E., Fraiz, N., Yanez, M., Terrades, V., Laguna, R., Cano, E., and Ravina, E. Pyridazines. Part XXIX: Synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Bioorg. Med. Chem., 10, 2873-2882 (2002).
16. Sotelo, E., Fraiz, N., Yanez, M., R. Laguna, E. Cano, and E. Ravina, Pyridazines. Part 31: Synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Chem. Pharm. Bull., 50, 1574-1577 (2002).
17. Szasz, G. and Budvavi-Bavauy, Z., Pharmaceutical Chemistry of Antihypertensive Agents, CRC Press, Boca Raton, 3-265 (1991).
18. Thyes, M., Lehmann, H. D., Gries, J., König, H., Kretzschmar, R., Kunze, J., Lebkücher, R., and Lenke, D., 6-Phenyl-4,5-dihydro-3-(2H)- pyridazinones. J. Med. Chem., 26, 800-807 (1983).
19. Tishler, M. and Stanovnik, B., Pyridazines. Adv. Heterocyclic Chem., 9, 121 (1968).
20. Tishler, M. and Stanovnik, B., Recent advances in pyridazine chemistry. Adv. Heterocyclic Chem., 24, 363 (1979).
21. Tishler, M. and Stanovnik, B., Advances in pyridazine chemistry. Adv. Heterocyclic Chem., 49, 385 (1990).
22. Turcki, I. J., Ed., The Chemistry of Heterocyclic Compounds, Oxazoles, An Intersciences Pub., John Wiley and Sons, p. 361-729 (1986).
23. Van der Mey, M., Boss, H., Couwenberg, D., Hatzelmann, A., Sterk, G. J., Goubitz, K., Schenk, H., and Timmerman, H., Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones. J. Med. Chem., 45, 2526-2533 (2002).
24. Wolf, M.E., Burger's Medicinal Chemistry And Drug Discovery 5th ed. Vol. 2, p. 152-462. John Wiley and Sons, New York (1997).
25. 2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)- phthalazinones. J. Med. Chem., 36, 4061-4068 (1993).
26. Zwieten, P. A. V. and Greenlee, W. J., Antihypertensive drugs, Harwood Academic Publishers, p. 1-528 (1997).